Thủy đậu - Hoàng Trường

 KC, Johnson JG: Varicella zoster virus transmission in the vaccine era: unmasking the 
role of herpes zoster. The Journal of infectious diseases 2012, 205(9):1331-1333. 
3. Whitley RJ: Varicella-Zoster Virus Infections. In: Harrison’s Infectious Diseases. edn. Edited 
by Dennis L. Kasper ASF. New York: The McGraw-Hill Companies, Inc; 2010: 740-744. 
4. Straus SE, Ostrove JM, Inchauspe G, Felser JM, Freifeld A, Croen KD, Sawyer MH: NIH 
conference. Varicella-zoster virus infections. Biology, natural history, treatment, and 
prevention. Annals of internal medicine 1988, 108(2):221-237. 
5. Weber DJ, Rutala WA, Hamilton H: Prevention and control of varicella-zoster infections in 
healthcare facilities. Infection control and hospital epidemiology 1996, 17(10):694-705. 
6. J.Whitley R: Chickenpox and Herpes zoster. In: Principles and Practice of Infectious Diseases. 
edn. Edited by Mandell GL BJ, Dolin R. Philadelphia,PA: Churchill Livingstone; 2015: 1731-
1737. 
7. Lee BW: Review of varicella zoster seroepidemiology in India and Southeast Asia. Tropical 
medicine & international health : TM & IH 1998, 3(11):886-890. 
8. CDC: Varicella. In: Epidemiology and Prevention of Vaccine-Preventable Diseases. 2th edn. 
Edited by Atkinson W HJ, Wolfe S. Washington DC: Public Health Foundation; 2012: 301-324. 
9. Jane Seward KG, Melinda Wharton: Epidemiology of varicella. In: Varicella-Zoster Virus: 
Virology and Clinical Management. edn. Edited by Ann M. Arvin AAG. Cambridge, United 
Kingdom: Cambridge University Press; 2000: 187-206. 
10. Arvin AM: Varicella-Zoster Virus. In: Principles and Practice of Pediatric Infectious Disease. 
edn. Edited by Sarah S. Long LKP, Charles G. Prober. United Kingdom: Churchill Livingstone; 
2012: 1035-1043. 
11. Charles Grose MY, Jorge Padilla, : Pathogenesis of primary infection. In: Varicella-Zoster 
Virus: Virology and Clinical Management. edn. Edited by Ann M. Arvin AAG. Cambridge, 
United Kingdom: Cambridge University Press; 2000: 105-124. 
12. LaRussa AAGP: VARICELLA-ZOSTER VIRUS INFECTIONS. In: Krugman's Infectious 
Diseases of Children 11th edition. Edited by Anne Gershon PH, Samuel Katz. Pennsylvania 
Elsevier, Inc; 2007: 981-1010. 
13. Gershon AA, Gershon MD: Pathogenesis and current approaches to control of varicella-
zoster virus infections. Clinical microbiology reviews 2013, 26(4):728-743. 
14. Chen JJ, Gershon AA, Li Z, Cowles RA, Gershon MD: Varicella zoster virus (VZV) infects 
and establishes latency in enteric neurons. Journal of neurovirology 2011, 17(6):578-589. 
15. Arvin AM, Moffat JF, Sommer M, Oliver S, Che X, Vleck S, Zerboni L, Ku CC: Varicella-
zoster virus T cell tropism and the pathogenesis of skin infection. Current topics in 
microbiology and immunology 2010, 342:189-209. 
16. Weigle KA, Grose C: Varicella pneumonitis: immunodiagnosis with a monoclonal antibody. 
The Journal of pediatrics 1984, 105(2):265-269. 
17. Sargent EN, Carson MJ, Reilly ED: Roentgenographic manifestations of varicella pneumonia 
with postmortem correlation. The American journal of roentgenology, radium therapy, and 
nuclear medicine 1966, 98(2):305-317. 
23 
18. Malavige GN, Jones L, Kamaladasa SD, Wijewickrama A, Seneviratne SL, Black AP, Ogg GS: 
Viral load, clinical disease severity and cellular immune responses in primary varicella 
zoster virus infection in Sri Lanka. PloS one 2008, 3(11):e3789. 
19. Gershon AA, Steinberg SP, Gelb L: Clinical reinfection with varicella-zoster virus. The 
Journal of infectious diseases 1984, 149(2):137-142. 
20. Ross AH: Modification of chicken pox in family contacts by administration of gamma 
globulin. The New England journal of medicine 1962, 267:369-376. 
21. LaRussa P: Clinical manifestations of varicella. In: Varicella-Zoster Virus: Virology and 
Clinical Management. edn. Edited by Ann M. Arvin AAG. Cambridge, United Kingdom: 
Cambridge University Press; 2000: 105-124. 
22. Ali N, Anwar M, Majeed I, Tariq WU: Chicken pox associated thrombocytopenia in adults. 
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2006, 16(4):270-272. 
23. Tunbridge AJ, Breuer J, Jeffery KJ: Chickenpox in adults - clinical management. The Journal 
of infection 2008, 57(2):95-102. 
24. Arvin AM: Varicella-zoster virus. Clinical microbiology reviews 1996, 9(3):361-381. 
25. Bovill B, Bannister B: Review of 26 years' hospital admissions for chickenpox in North 
London. The Journal of infection 1998, 36 Suppl 1:17-23. 
26. Fleisher G, Henry W, McSorley M, Arbeter A, Plotkin S: Life-threatening complications of 
varicella. American journal of diseases of children (1960) 1981, 135(10):896-899. 
27. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A: Invasive group A 
streptococcal disease in children and association with varicella-zoster virus infection. 
Ontario Group A Streptococcal Study Group. Pediatrics 2000, 105(5):E60. 
28. Vugia DJ, Peterson CL, Meyers HB, Kim KS, Arrieta A, Schlievert PM, Kaplan EL, Werner SB: 
Invasive group A streptococcal infections in children with varicella in Southern California. 
The Pediatric infectious disease journal 1996, 15(2):146-150. 
29. Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE: A case-control study of 
necrotizing fasciitis during primary varicella. Pediatrics 1999, 103(4 Pt 1):783-790. 
30. Popara M, Pendle S, Sacks L, Smego RA, Jr., Mer M: Varicella pneumonia in patients with 
HIV/AIDS. International journal of infectious diseases : IJID : official publication of the 
International Society for Infectious Diseases 2002, 6(1):6-8. 
31. Fehr T, Bossart W, Wahl C, Binswanger U: Disseminated varicella infection in adult renal 
allograft recipients: four cases and a review of the literature. Transplantation 2002, 
73(4):608-611. 
32. Pugh RN, Omar RI, Hossain MM: Varicella infection and pneumonia among adults. 
International journal of infectious diseases : IJID : official publication of the International 
Society for Infectious Diseases 1998, 2(4):205-210. 
33. Mohsen AH, Peck RJ, Mason Z, Mattock L, McKendrick MW: Lung function tests and risk 
factors for pneumonia in adults with chickenpox. Thorax 2001, 56(10):796-799. 
34. Baren JM, Henneman PL, Lewis RJ: Primary varicella in adults: pneumonia, pregnancy, and 
hospital admission. Annals of emergency medicine 1996, 28(2):165-169. 
35. Ellis ME, Neal KR, Webb AK: Is smoking a risk factor for pneumonia in adults with 
chickenpox? British medical journal (Clinical research ed) 1987, 294(6578):1002. 
36. Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, Paul R, Miodovnik 
M, Dombrowski M, Sibai B et al: Risk factors and outcome of varicella-zoster virus 
pneumonia in pregnant women. The Journal of infectious diseases 2002, 185(4):422-427. 
37. Feldman S: Varicella-zoster virus pneumonitis. Chest 1994, 106(1 Suppl):22s-27s. 
38. Dits H, Frans E, Wilmer A, Van Ranst M, Fevery J, Bobbaers H: Varicella-zoster virus 
infection associated with acute liver failure. Clinical infectious diseases : an official 
publication of the Infectious Diseases Society of America 1998, 27(1):209-210. 
39. Russell LK: Management of varicella-zoster virus infection during pregnancy and the 
peripartum. Journal of nurse-midwifery 1992, 37(1):17-24. 
24 
40. Gershon AA: Varicella-zoster virus: prospects for control. Advances in pediatric infectious 
diseases 1995, 10:93-124. 
41. Tan MP, Koren G: Chickenpox in pregnancy: revisited. Reproductive toxicology (Elmsford, 
NY) 2006, 21(4):410-420. 
42. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M: Consequences of varicella and 
herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994, 343(8912):1548-
1551. 
43. Immunisation against infectious disease, ‘‘The Green Book’’. In: Varicella. London: 
Departement of health; 2006. 
44. Anne Lee JT: Drug-induced skin reactions. In: Adverse Drug Reactions. edn. Edited by Lee A: 
Pharmaceutical Press; 2006: 125-153. 
45. Prober CG, Kirk LE, Keeney RE: Acyclovir therapy of chickenpox in immunosuppressed 
children--a collaborative study. The Journal of pediatrics 1982, 101(4):622-625. 
46. Bennet R, Forsgren M, Herin P: Herpes zoster in a 2-week-old premature infant with possible 
congenital varicella encephalitis. Acta paediatrica Scandinavica 1985, 74(6):979-981. 
47. [Management of varicella-zona virus infections. A consensus conference of the French-
speaking Society of Infectious Pathology, Lyon, 25 March 1998]. Archives de pediatrie : 
organe officiel de la Societe francaise de pediatrie 1999, 6(4):469-476. 
48. Zachary KC: Acyclovir: An overview. In: Up to date. 2013 edn. USA: Wolters Kluwer Health 
2013. 
49. Klassen TP, Hartling L, Wiebe N, Belseck EM: Acyclovir for treating varicella in otherwise 
healthy children and adolescents. The Cochrane database of systematic reviews 
2005(4):Cd002980. 
50. Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S: 
Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live 
varicella vaccine. Pediatrics 1994, 94(4 Pt 1):524-526. 
51. Vắcxin Varicella [
c3453i4341.htm] 
52. FDA approval of an extended period for administering VariZIG for postexposure 
prophylaxis of varicella. MMWR Morbidity and mortality weekly report 2012, 61(12):212. 
53. King SM, Gorensek M, Ford-Jones EL, Read SE: Fatal varicella-zoster infection in a newborn 
treated with varicella-zoster immunoglobulin. Pediatric infectious disease 1986, 5(5):588-589. 
54. Daley AJ, Thorpe S, Garland SM: Varicella and the pregnant woman: prevention and 
management. The Australian & New Zealand journal of obstetrics & gynaecology 2008, 
48(1):26-33. 
55. Macartney K, Heywood A, McIntyre P: Vaccines for post-exposure prophylaxis against 
varicella (chickenpox) in children and adults. The Cochrane database of systematic reviews 
2014, 6:Cd001833.